9 results
8-K
EX-99.1
TLPH
Talphera Inc.
17 May 21
AcelRx Pharmaceuticals Reports First Quarter 2021 Financial Results
4:10pm
profile for all demographic subgroups following the dosing of DSUVIA. See Cautionary Statements section below.
In March 2021, AcelRx announced
8-K
EX-1.1
v1g98jrbfikbnhhusaid
21 Jan 21
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
m6d1lmi0 yod
6 Nov 19
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results
4:26pm
8-K
EX-1.1
iqy5vf5q
13 Nov 18
Other Events
5:18pm
8-K
EX-1.1
9il4khkl
13 Jul 18
Other Events
4:03pm
- Prev
- 1
- Next